US to hike fees for generic drugmakers; Indian firms to be hit
Washington: Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. India is ...